Zaina Jasser urges patients and medical practitioners to be cautious of the moral and sociological implications of ...

But last year, the weight-loss drug Wegovy ... prescriptions of other drugs among those patients fell by about 3%. Those who received the drugs were just a fraction of young people who struggle ...

Weight loss drugs are getting more popular, even for teenagers and pre-teens -- but while many doctors have reported ...

The results supported the widely held theory among ... soar, many companies are instead making it harder for people to get their hands on weight-loss drugs. They started by cracking down on use ...

As semaglutide gains popularity for weight loss, youth express significant concerns about its safety and appropriate use, particularly given their heightened engagement with social media and ...

Ore Huiying / Bloomberg / Getty Images Shares of Eli Lilly jumped 16% Thursday morning after the pharmaceutical company released Phase 3 trial results for its oral weight-loss drug that ...

Eli Lilly's Oral GLP-1 Drug Orforglipron Hits Phase 3 Goals In Diabetes Trial, Stock Soars Skye Bioscience's Obesity Candidate Shows 30% Weight Loss When Combined With Eli Lilly's Blockbuster Drug ...

(Bloomberg) -- Eli Lilly & Co. shares surged after its experimental pill helped patients shed weight and control blood ... Shares of the drug’s originator Chugai Pharmaceutical Co. also soared.

Its main obesity trial won’t wrap until at least July, according to a clinical trial database, and those results are among the most ... selling diabetes and weight-loss drugs Ozempic and Wegovy ...

Eli Lilly on Thursday reported promising results for a daily pill that could serve as an alternative to injectable weight-loss and diabetes drugs. One thing hampering the GLP-1 drug boom is the ...